News

The Ozempic maker's stock tanked after its highly anticipated CagriSema drug trial showed an average of 22.7% weight loss, below expectations for 25%.

Adrian Alexandru, representing all similarly affected investors, has filed a federal securities class-action lawsuit against Applied Therapeutics (NASDAQ:APLT), alleging the company violated federal securities laws. The lawsuit claims that the company provided misleading information about its clinical trials and failed to disclose key adverse facts, causing significant financial losses for shareholders. Also Read: Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbust

It's perfectly legal to use life insurance to save millions on taxes – for now.

Donald Trump triggered a turbulent end to the week as stocks plunged after he called for a US government shutdown to “begin now” under Biden, rather than under his administration.

The logistics giant hopes to unlock more value in making FedEx Freight a standalone public company, all while competing for more volume.

Nike shares lost ground Friday morning after the athletic apparel company warned that its turnaround efforts will take time and weigh on short-term results. Monitor these key chart levels.

(Bloomberg) -- European stocks posted the biggest weekly decline in over three months, as Danish drugmaker Novo Nordisk A/S sank 21% after a study showed underwhelming results from its obesity drug trial.Most Read from BloombergNew York City’s Historic Preservation Movement Is Having a Midlife CrisisThe Architects Who Built MiamiReviving a Little-Known Modernist Landmark in BuffaloNYPD Car Chases Are Becoming More Frequent — and More DangerousDakar’s Air Quality Plummets as Saharan Dust Descends